Paid Clinical Trials Albuquerque

Discover 380 paid clinical trials in Albuquerque. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 380

Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)

Recruiting

PHASE3

Sponsor:

GB002, Inc.

Location:

Albuquerque, Aurora, Murray, Oklahoma Cityshow 47 more

Code:

NCT05934526

Conditions

Pulmonary Arterial Hypertension

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Placebo

Seralutinib

Generic Dry Powder Inhaler

Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)

Recruiting

PHASE3

Sponsor:

VistaGen Therapeutics, Inc.

Location:

Albuquerque, Denver, Las Vegas, Austinshow 8 more

Code:

NCT06615557

Conditions

Social Anxiety Disorder (SAD)

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Fasedienol Nasal Spray

Placebo Nasal Spray

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Albuquerque, El Paso, Amarillo, Tucsonshow 195 more

Code:

NCT06283966

Conditions

COPD (Chronic Obstructive Pulmonary Disease)

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

BGF MDI 320/14.4/9.6 μg

GFF MDI 14.4/9.6 μg

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Albuquerque, Rio Rancho, Durango, Las Crucesshow 638 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D).

Recruiting

PHASE2

Sponsor:

CinPhloro Pharma, LLC

Location:

Albuquerque, Phoenix, Sun City, Las Vegasshow 43 more

Code:

NCT06153420

Conditions

Irritable Bowel Syndrome With Diarrhea

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CIN-103

Placebo

A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo

Recruiting

PHASE3

Sponsor:

Pfizer

Location:

Albuquerque, Dallas, San Antonio, Encinitasshow 23 more

Code:

NCT06163326

Conditions

Vitiligo

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Ritlecitinib

Ritlecitinib 100 mg

Placebo

A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo

Recruiting

PHASE3

Sponsor:

Pfizer

Location:

Albuquerque, Dallas, San Antonio, Encinitasshow 46 more

Code:

NCT05583526

Conditions

Stable Nonsegmental Vitiligo

Active Nonsegmental Vitiligo

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Ritlecitinib

Placebo

Individualized Targeting and Neuromodulation of Late-Life Depression

Recruiting

Sponsor:

University of New Mexico

Location:

Albuquerque

Code:

NCT04543773

Conditions

Major Depressive Disorder

Eligibility Criteria

Sex: All

Age: 60 - 70+

Healthy Volunteers: Not accepted

Interventions

rTMS

Comparing Two Methods to Follow Patients With Pancreatic Cysts

Recruiting

Sponsor:

ECOG-ACRIN Cancer Research Group

Location:

Albuquerque, Scottsdale, Phoenix, Salt Lake Cityshow 224 more

Code:

NCT04239573

Conditions

Pancreatic Carcinoma

Eligibility Criteria

Sex: All

Age: 50 - 70+

Healthy Volunteers: Not accepted

Interventions

Computed Tomography

Endoscopic Ultrasound

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

Study to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney Disease

Recruiting

PHASE3

Sponsor:

Keryx Biopharmaceuticals

Location:

Albuquerque, Phoenix, Aurora, Salt Lake Cityshow 9 more

Code:

NCT04523727

Conditions

Hyperphosphatemia Related to Chronic Kidney Disease

Eligibility Criteria

Sex: All

Age: 6 - 16

Healthy Volunteers: Not accepted

Interventions

ferric citrate